The EURAS project received over 8 million euros funding from the Health Cluster of the Horizon Europe Research and Innovation Programme
Rare neurodevelopmental disorders of the Ras pathway continue to evade effective treatment. The EURAS consortium has been awarded over 8 million euros from the Health Cluster of the Horizon Europe Research and Innovation Programme to develop new effective therapies and establish a framework for early, accurate diagnosis of neurological symptoms in a specific group of RASopathies (cardio-facio-cutaneous syndrome, Costello syndrome and SYNGAP1-related encephalopathy).
– The consortium will identify disease signatures, develop new and use existing disease models, identify and validate new therapeutic approaches and brain delivery systems and, with patient organisations from 13 countries, establish a patient registry for stratification and evaluation of therapeutic approaches, says group leader and Senior Research Fellow Michael Courtney from Turku Bioscience Centre, University of Turku. > Keep reading
> Read more about the consortium
There is a position available on this project, application deadline is on 19 June 2023.
Recent Posts
- New computational tool helps scientists interpret complex single-cell data Researchers from Laura Elo’s group, have developed a new computational method to interpret complex single-cell Read moreNovember 17, 2025
- Carlos Rogério Figueiredo received the Young Investigator Award Carlos Rogério Figueiredo has received the Young Investigator Award from the Scandinavian Society for Immunology. Read moreNovember 4, 2025
- Participate to Open Hardware Workshop, sign up now! Access to research hardware remains a global challenge and it impacts also researchers in high-income Read moreNovember 3, 2025
- The Academy of Finland granted Johanna Ivaska €2,400,000 in funding for an Academy Professor position The Academy of Finland granted our Group Leader, Professor Johanna Ivaska €2,400,000 in funding for Read moreOctober 30, 2025
- Guillaume Jacquemet and Cecilia Sahlgren receive funding for the Research Council of Finland Centre of Excellence in Immune-Endothelial Interactions (IMMENs) Associate Professor Guillaume Jacquemet, our Group Leader, and Professor Cecilia Sahlgren, our affiliated Group Leader, Read moreOctober 30, 2025
- Registration to AI2Med imaging event is now open! Registration for AI2Med Turku 2025 is open! The event is organized by the Turku PET Read moreOctober 21, 2025